Supreme Court of Canada opens hearings on safe drug injection facility

NewsGuard 100/100 Score

The Supreme Court of Canada on Thursday began hearing the Canadian government's case against Insite, a Vancouver-based legal injection site where people can obtain clean needles and syringes to inject their own drugs under a nurse's supervision, the Canadian Press reports. Proponents of the program say it "prevents overdose deaths, reduces the spread of HIV and hepatitis, and curbs crime and open drug use" (5/12).

Those defending the facility argue that it provides "a form of health care, and that health care is a provincial matter under Canada's constitution. The federal government counters that its writ trumps provincial rights because heroin is a federally banned substance," the Associated Press writes (5/11). The court is tasked with determining "whether federal drug laws or provincial health care interests have power over Insite and whether it would violate the Charter rights of drug users to shut it down. One of the government's core arguments is that public safety is just as important as public health," according to The Province (Ross, 5/12).

Vancouver Mayor Gregor Robertson and five former mayors on Tuesday sent a letter to the federal government supporting the continued operation of Insite, the Vancouver Sun reports (Lee/Tibbetts, 5/11).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New hope for binge eating and bulimia: GLP-1 drugs could be the key